Crossmark

Defining the current models of immunization of immunocompromised patients in Spain, and how to improve them: results of the CARABELA-IP initiative

Crossref DOI link: https://doi.org/10.1016/j.vacun.2026.500634

Published Print: 2026-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Pérez-Martín, Jaime

de la Vega, Manuel García

Montes, Gregorio

Mediavilla, Inmaculada

Soto, José Francisco

Escudero, Luciano

González, Marta Eva

Nartallo, Victoria

Fernández-Prada, María
Funding

Funding for this research was provided by:

AstraZeneca España
License Information

Text and Data Mining valid from 2026-04-01

Text and Data Mining valid from 2026-04-01

stm-asf valid from 2026-04-01

stm-asf valid from 2026-04-01

stm-asf valid from 2026-04-01

stm-asf valid from 2026-04-01

stm-asf valid from 2026-04-01
More Information

This article is maintained by: Elsevier

Article Title: Defining the current models of immunization of immunocompromised patients in Spain, and how to improve them: results of the CARABELA-IP initiative

Journal Title: Vacunas

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.vacun.2026.500634

Content Type: article

Copyright: © 2026 Published by Elsevier España, S.L.U.